Class Action Filed Against ESSA Pharma Inc. (EPIX) Seeking Recovery For Investors – Contact The Gross Law Firm
Shareholders who purchased shares of EPIX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required ...
Targeted Oncology22h
Therapeutic options for a patient with mCRPC after ADT + docetaxel
An expert discusses the therapeutic options included in the NCCN guidelines for metastatic castration-resistant prostate ...
The American Journal of Managed Care16h
Getting More Doctors to Record a Life-Saving Prostate Cancer Calculation
Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...
Metastatic Prostate Cancer Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
DelveInsight’s, “Metastatic Prostate Cancer Pipeline Insight” report provides comprehensive insights about 80+ companies and 85+ pipeline drugs in metastatic prostate cancer pipeline landscape. It ...